Search Within

Kevin Joseph Curran

  1. "Pediatrics, Department of"
Formats
  1. Meeting Abstract (84)
  2. Journal Article (53)
  3. Review (6)
  4. Research Letter (4)
Groups
  1. Pediatrics, Department of (147)
  2. Stem Cell Transplantation and Cellular Therapy Service (147)
  3. Department of Medicine (102)
  4. Center for Hematologic Malignancies (93)
  5. GSK Faculty (93)
  6. Hematologic Malignancies, Division of (78)

More Groups

People
  1. Nancy Kernan (52)
  2. Richard O'Reilly (52)
  3. Andromachi Scaradavou (50)
  4. Renier Brentjens (47)
  5. Jaap Jan Boelens (45)
  6. Farid Boulad (42)

More People

Years
  1. 2025 (6)
  2. 2024 (13)
  3. 2023 (16)
  4. 2022 (16)
  5. 2021 (13)
  6. 2020 (13)

More Years

Publications
  1. Blood (38)
  2. Bone Marrow Transplantation (15)
  3. Biology of Blood and Marrow Transplantation (12)
  4. Blood Advances (11)
  5. Pediatric Blood and Cancer (10)
  6. Cytotherapy (9)

More Publications

Publishers
  1. American Society of Hematology (50)
  2. Nature Publishing Group (26)
  3. Elsevier Inc. (21)
  4. Wiley Periodicals, Inc (10)
  5. Elsevier Science Ltd. (9)
  6. American Society of Clinical Oncology (8)

More Publishers

Results (147)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • CAR T-cells followed by CD34-selected T-cell depleted (TCD) ALLO-HSCT is associated with low toxicity and favorable overall survival
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M.; Margossian, S.; Mauguen, A.; Prockop, S.; Scaradavou, M.; Shah, N.; Spitzer, B.; Stieglitz, E.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult ALL
    Meeting Abstract

    Perica, K.; Flynn, J.; Curran, K. J.; Wang, X.; Halton, E.; Diamonte, C.; Pineda, J.; Bernal, Y.; Gonen, M.; Riviere, I.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Identification of infants with non-SCID immune deficiency by newborn screening for SCID - The Memorial Sloan Kettering Cancer Center experience
    Meeting Abstract

    Prockop, S.; Spitzer, B.; Walsh, M.; Ruggiero, J.; Kennedy, J.; Boulad, F.; Cancio, M.; Curran, K.; Kernan, N.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Conditioning prior to CD19-specific CAR (19-28Z) T cells predicts response and survival in pediatric relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K.; Margossian, S.; Kernan, N.; Prockop, S.; Boulad, F.; Cancio, M.; Szenes, V.; Kung, A.; Boelens, J. J.; O'Reilly, R.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Utilization of CAR T cell therapy in pediatric patients
    Review

    Szenes, V.; Curran, K. J.
    Seminars in Oncology Nursing (2019)

    Fulltext@MSK | Save
  • CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma
    Journal Article

    Sauter, C. S.; Senechal, B.; Rivière, I.; Ni, A.; Bernal, Y.; Wang, X.; Purdon, T.; Hall, M.; Singh, A. N.; Szenes, V. Z.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • BIANCA: A phase 2 study of the safety and efficacy of tisagenlecleucel in pediatric patients with relapsed/refractory mature B‐cell non-Hodgkin lymphoma
    Meeting Abstract

    Minard‐Colin, V.; Burkhardt, B.; Maude, S.; Phillips, C.; Diaz de Heredia Rubio, C.; Laetsch, T. W.; Curran, K.; Newsome, S.; Murray, N.; Pacaud, L.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells
    Review

    Lee, D. W.; Santomasso, B. D.; Locke, F. L.; Ghobadi, A.; Turtle, C. J.; Brudno, J. N.; Maus, M. V.; Park, J. H.; Mead, E.; Pavletic, S.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • CD40 ligand-modified chimeric antigen receptor T cells enhance antitumor function by eliciting an endogenous antitumor response
    Journal Article

    Kuhn, N. F.; Purdon, T. J.; van Leeuwen, D. G.; Lopez, A. V.; Curran, K. J.; Daniyan, A. F.; Brentjens, R. J.
    Cancer Cell (2019)

    Fulltext@MSK | Save